Title: Controlled Substances (Prohibited Substances) VariationRegulations 2007
Subject: Controlled SubstancesAct 1984
Author: Office of Parliamentary Counsel
Category: public
Document comments: 264

No 264 of 2007 published in Gazette 22.11.2007 p 4308

Controlled Substances (Prohibited Substances) Variation Regulations 2007

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Part 1—Preliminary

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Preliminary—Part 1

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Part 2—Variation of Controlled Substances (Prohibited Substances) Regulations 2000

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Variation of Controlled Substances (Prohibited Substances) Regulations 2000—Part 2

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Part 2—Variation of Controlled Substances (Prohibited Substances) Regulations 2000
Schedule 3—Controlled Plants
Part 1—Controlled plants other than cannabis plants

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Variation of Controlled Substances (Prohibited Substances) Regulations 2000—Part 2
Controlled Plants—Schedule 3
Controlled plants other than cannabis plants—Part 1

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Schedule 1—Revocation

Controlled Substances (Prohibited Substances) Variation Regulations 2007
Revocation—Schedule 1

South Australia
Controlled Substances (Prohibited Substances) Variation Regulations 2007
under the Controlled Substances Act 1984

Contents
Part 1—Preliminary
1	Short title
2	Commencement
3	Variation provisions
Part 2—Variation of Controlled Substances (Prohibited Substances) Regulations 2000
4	Variation of regulation 1—Short title
5	Revocation of regulations 2 and 3
6	Variation of regulation 4—Interpretation
7	Substitution of regulations 5 to 8
5	Declaration of controlled drugs, controlled precursors and controlled plants
6	Prescribed quantities of controlled drugs, controlled precursors and controlled plants
7	Prescribed number of cannabis plants (section 33K)
8	Exemption from prohibition of possession of injecting equipment
8A	No accessorial liability in prescribed circumstances
8	Variation of regulation 9—Prescribed place
9	Insertion of regulations 9A and 9B
9A	Expiation fees for simple cannabis offences
9B	Simple cannabis offences
10	Variation of regulation 11—Prescribed manner of initiation of analysis and prescribed fee
11	Insertion of regulations 14, 15 and 16
14	Prescribed professional associations
15	Corresponding laws
16	Copies of codes etc to be kept available for public inspection
12	Substitution of Schedules 1, 2 and 3
Schedule 1—Controlled Drugs
Part 1—Controlled Drugs other than drugs of dependence
Part 2—Drugs of dependence
Schedule 2—Controlled Precursors
Schedule 3—Controlled Plants
Part 1—Controlled plants other than cannabis plants
Part 2—Cannabis plants
13	Insertion of Schedule 5
Schedule 5—Expiation Fees
Schedule 1—Revocation
1	Revocation of Controlled Substances (Expiation of Simple Cannabis Offences) Regulations 2002
2	Revocation of Controlled Substances (Exemptions) Regulations 2004

Part 1—Preliminary
1—Short title
These regulations may be cited as the Controlled Substances (Prohibited Substances) Variation Regulations 2007.
2—Commencement
These regulations will come into operation on the day on which section 14 of the Controlled Substances (Serious Drug Offences) Amendment Act 2005 comes into operation.
3—Variation provisions
In these regulations, a provision under a heading referring to the variation of specified regulations varies the regulations so specified.

Part 2—Variation of Controlled Substances (Prohibited Substances) Regulations 2000
4—Variation of regulation 1—Short title
Regulation 1—delete "Prohibited Substances" and substitute:
General
5—Revocation of regulations 2 and 3
Regulations 2 and 3—delete the regulations
6—Variation of regulation 4—Interpretation
Regulation 4, definition of schedule 8—delete the definition
7—Substitution of regulations 5 to 8
Regulations 5 to 8—delete regulations 5 to 8 (inclusive) and substitute:
5—Declaration of controlled drugs, controlled precursors and controlled plants
	(1)	In accordance with section 12(4) of the Act, the following substances are declared to be controlled drugs:
	(a)	the natural or synthetic form of a substance listed in Schedule 1;
	(b)	any salt, derivative or isomer of the natural or synthetic form of a substance listed in Schedule 1 and any salt of such derivative or isomer;
	(c)	any analogue of the natural or synthetic form of a substance listed in Schedule 1 (being an analogue having a substantially similar chemical structure to the substance, but differing in elemental composition due to the addition, deletion or replacement of any substituent element or group);
	(d)	any homologue of the natural or synthetic form of a substance listed in Schedule 1 (being a homologue differing from the substance by 1 or more carbon containing groups (including methylene groups) in the chemical structure);
	(e)	any of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.
	(2)	In accordance with section 12(4a) of the Act, the following substances are declared to be controlled precursors:
	(a)	the natural or synthetic form of a substance listed in Schedule 2;
	(b)	any salt, isomer, ester, ether, ketal, acetal, acetate, hydroxide, oxime, amide, imine, acid chloride, nitrile, anhydride, halogen substituent, epoxide, diol or any analogue or derivative of the natural or synthetic form of a substance listed in Schedule 2;
	(c)	any of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.
	(3)	In accordance with section 12(4b) of the Act, the following plants are declared to be controlled plants:
	(a)	a growing plant listed in Schedule 3 Part 1;
	(b)	a cutting taken from a plant listed in Schedule 3 Part 1 (provided that the cutting has been planted or otherwise placed in a growing medium).
6—Prescribed quantities of controlled drugs, controlled precursors and controlled plants
	(1)	For the purposes of the definition of large commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug, controlled precursor or controlled plant prescribed as a large commercial quantity of the drug, precursor or plant in its pure form is—
	(a)	in the case of a controlled drug—the amount (if any) listed in the column headed "Large commercial (pure)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
	(b)	in the case of a controlled precursor—the amount (if any) listed in the column headed "Large commercial (pure)" of the table in Schedule 2 opposite the entry listing the controlled precursor; or
	(c)	in the case of a controlled plant—the amount (if any) listed in the column headed "Large commercial" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
	(2)	For the purposes of the definition of large commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug prescribed as a large commercial quantity for any mixture containing the controlled drug is the amount (if any) listed in the column headed "Large commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
	(3)	For the purposes of the definition of commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug, controlled precursor or controlled plant prescribed as a commercial quantity of the drug, precursor or plant in its pure form is—
	(a)	in the case of a controlled drug—the amount (if any) listed in the column headed "Commercial (pure)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
	(b)	in the case of a controlled precursor—the amount (if any) listed in the column headed "Commercial (pure)" of the table in Schedule 2 opposite the entry listing the controlled precursor; or
	(c)	in the case of a controlled plant—the amount (if any) listed in the column headed "Commercial" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
	(4)	For the purposes of the definition of commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug prescribed as a commercial quantity for any mixture containing the controlled drug is the amount (if any) listed in the column headed "Commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
	(5)	For the purposes of the definition of trafficable quantity in section 4(1) of the Act, the quantity of a particular controlled plant prescribed as a trafficable quantity of the controlled plant in its pure form is the amount (if any) listed in the column headed "Trafficable" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
	(6)	For the purposes of the definition of trafficable quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug prescribed as a trafficable quantity for any mixture containing the controlled drug is the amount (if any) listed in the column headed "Trafficable (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
7—Prescribed number of cannabis plants (section 33K)
For the purposes of section 33K of the Act, the prescribed number of cannabis plants is 5.
8—Exemption from prohibition of possession of injecting equipment
Section 33L(1)(c) of the Act does not apply to a person having in his or her possession a syringe or needle for use in connection with the administration of a controlled drug.
8A—No accessorial liability in prescribed circumstances
	(1)	For the purposes of section 33S, a circumstance consisting of the sale or supply of syringes or needles, or the giving of advice or instruction on the safe use of syringes or needles, by—
	(a)	a medical practitioner; or
	(b)	a pharmacist; or
	(c)	a person acting in the course of a health risk minimisation program,
is prescribed.
	(2)	In this regulation—
health risk minimisation program means a program—
	(a)	designed to facilitate—
	(i)	the supply to intravenous drug users of sterile syringes and sterile needles, and any associated equipment, to prevent the spread of infectious diseases and minimise health risks associated with intravenous drug use; and
	(ii)	the giving out of information concerning safe practices in the use of syringes and needles to prevent the spread of infectious diseases; and
	(b)	declared by the Minister, by notice in writing given personally or by post to the person responsible for conducting the program, to be a health risk minimisation program for the purposes of this regulation.
	(3)	The Minister may, by subsequent notice in writing given personally or by post to the person responsible for conducting the program, vary or revoke the declaration.
8—Variation of regulation 9—Prescribed place
Regulation 9—delete "and (db)"
9—Insertion of regulations 9A and 9B
After regulation 9 insert:
9A—Expiation fees for simple cannabis offences
In accordance with section 45A(3) of the Act, the fees fixed for the expiation of simple cannabis offences are set out in Schedule 5.
9B—Simple cannabis offences
	(1)	For the purposes of paragraph (a) of the definition of simple cannabis offence in section 45A(8) of the Act, the prescribed number of cannabis plants is 1.
	(2)	For the purposes of paragraph (b) of the definition of simple cannabis offence in section 45A(8) of the Act, the following quantities of cannabis, cannabis resin and cannabis oil are prescribed:
	(a)	in the case of cannabis—100 grams;
	(b)	in the case of cannabis resin—20 grams;
	(c)	in the case of cannabis oil—0 millilitres.
	(3)	For the purposes of paragraph (c) of the definition of simple cannabis offence in section 45A(8) of the Act, a motor vehicle, train, tram or any other vehicle is, while in a public place, prescribed.
10—Variation of regulation 11—Prescribed manner of initiation of analysis and prescribed fee
Regulation 11(b)—delete "$150" and substitute:
$207
11—Insertion of regulations 14, 15 and 16
After regulation 13 insert:
14—Prescribed professional associations
For the purposes of section 58(1a) of the Act, the following professional associations are prescribed:
	(a)	in the case of publishing information to medical practitioners—
	(i)	Adelaide Northern Division of General Practice; and
	(ii)	Australian Medical Association; and
	(iii)	Murray Mallee Division of General Practice; and
	(iv)	Western Division of Mental Health; and
	(v)	Royal Australian College of General Practitioners; and
	(vi)	Friendly Societies Medical Association;
	(b)	in the case of publishing information to pharmacists—
	(i)	Pharmaceutical Society of Australia (SA Branch); and
	(ii)	Pharmacy Guild of Australia (SA Branch).
15—Corresponding laws
For the purposes of section 61(4) of the Act, the following laws are prescribed:
	(a)	the Drugs of Dependence Act 1989 of the Australian Capital Territory;
	(b)	the Drugs Misuse and Trafficking Act 1985 of New South Wales;
	(c)	the Misuse of Drugs Act of the Northern Territory;
	(d)	the Drugs Misuse Act 1986 of Queensland;
	(e)	the Poisons Act 1971 of Tasmania;
	(f)	the Drugs, Poisons and Controlled Substances Act 1981 of Victoria;
	(g)	the Misuse of Drugs Act 1981 of Western Australia.
16—Copies of codes etc to be kept available for public inspection
For the purposes of section 63(5a) of the Act, the office of Drug and Alcohol Services South Australia at 168 Greenhill Road, Parkside is specified as the place at which copies of any relevant codes, standards, pharmacopoeia and other documents must be kept and made available for inspection by members of the public.
12—Substitution of Schedules 1, 2 and 3
Schedules 1, 2 and 3—delete Schedules 1, 2 and 3 and substitute:
Schedule 1—Controlled Drugs
Part 1—Controlled Drugs other than drugs of dependence

| Large commercial (pure) | Large commercial (mixed) | Commercial (pure) | Commercial (mixed) | Trafficable (mixed)
| kg | kg | kg | kg | g
Acetorphine | | 2 | | 0.5 | 3
Acetyl‑alpha‑methylfentanyl | | 0.005 | | 0.00125 | 0.0075
Allylprodine | | 1 | | 0.25 | 1.5
Alpha‑methylfentanyl | | 0.005 | | 0.00125 | 0.0075
Alpha‑methylthiofentanyl | | 0.005 | | 0.00125 | 0.0075
5-(2‑aminopropyl)indan | | 1 | | 0.25 | 3
3-(2‑aminopropyl)indole (AMT) | | 0.2 | | 0.05 | 5
Benzethidine | | 10 | | 2.5 | 15
Benzoylecgonine | | 1 | | 0.25 | 3
1‑Benzylpiperazine (BZP) | | 1 | | 0.25 | 3
Beta‑hydroxyfentanyl | | 0.005 | | 0.00125 | 0.0075
Beta‑hydroxy‑3‑methylfentanyl | | 0.005 | | 0.00125 | 0.0075
4‑Bromo‑2,5‑dimethoxyamphetamine | | 0.2 | | 0.05 | 5
Bufotenine | | 2 | | 0.5 | 50
1,4‑Butanediol | | 2 | | 0.5 | 50
Cannabis - oil (other than hemp seed oil) | 2 | 10 | 1 | 2 | 25
Cannabis - resin | 2 | 10 | 1 | 2 | 25
Cannabinoid - dried plant material including flowering and fruiting tops, leaves, seeds or stalks but not including oil or resin | 2 | 12.5 | 1 | 2.5 | 250
Cathinone | | 5 | | 1.25 | 6
1‑(3‑Chlorophenyl)piperazine | | 1 | | 0.25 | 3
Clonitazene | | 5 | | 1.25 | 7.5
Codoxime | | 10 | | 2.5 | 15
4‑Cyano2‑dimethyl‑amino‑4,4‑diphenylbutane (methadone intermediate) | | 2 | | 0.5 | 3
4‑Cyano‑1‑methyl‑4‑phenylpiperidine (pethidine intermediate A) | | 1 | | 0.25 | 3
Delta‑9‑tetrahydrocannabinol (dronabinol) | 4 | 25 | 1 | 10 | 25
Desomorphine | | 2 | | 0.5 | 3
Diampromide | | 5 | | 1.25 | 7.5
Diethylthiambutene | | 5 | | 1.25 | 7.5
N,N‑Diethyltryptamine | | 2 | | 0.5 | 3
Dihydrohydroxymorphine | | 10 | | 2.5 | 250
Dimenoxadol | | 10 | | 2.5 | 125
Dimepheptanol | | 10 | | 2.5 | 125
N,N-Dimethylamphetamine | | | | |
3-(1,2-Dimethylheptyl)‑1‑hydroxy‑7,8,9,10‑tetrahydro‑6, 6,9‑trimethyl‑6h‑dibenzo (b,d) pyran (DMHP) | | 2 | | 0.5 | 3
Dimethylthiambutene | | 5 | | 1.25 | 7.5
N:N‑Dimethyltryptamine | | 2 | | 0.5 | 3
2,5-Dimethoxy‑4-ethylthiophenethylamine | 0.75 | 1 | 0.1 | 0.5 | 2
2,5-Dimethoxy‑4-iodophenethylamine | 0.75 | 1 | 0.1 | 0.5 | 2
2,5-Dimethoxy‑4-(N)-propylthiophenethylamine | 0.75 | 1 | 0.1 | 0.5 | 2
Dioxaphetylbutyrate | | 2 | | 0.5 | 3
Ecgonine | | 1 | | 0.25 | 3
4,5‑Ethylenedioxy‑3-methoxyamphetamine | | | | |
Ethylmethylthiambutene | | 5 | | 1.25 | 7.5
N‑Ethyl‑1‑phenylcyclohexylamine | | 0.4 | | 0.1 | 0.0075
Eticyclidine (PCE) | | 0.004 | | 0.001 | 0.0075
Etonitazene | | 5 | | 1.25 | 7.5
Etorphine | | 5 | | 1.25 | 7.5
Etoxeridine | | 5 | | 1.25 | 7.5
Fenethylline | | 2 | | 0.5 | 3
Furethidine | | 1 | | 0.25 | 1.5
Harmaline | | 5 | | 1.25 | 20
Harmine | | 5 | | 1.25 | 20
Harmines (not otherwise listed in this Schedule) | | 5 | | 1.25 | 20
Heroin (diacetylmorphine/diamorphine) | 0.75 | 1 | 0.1 | 0.2 | 2
3‑Hexyl‑1‑hydroxy‑7,8,9,10‑tetrahydro-6,6,9- trimethyl‑6H‑dibenzo (b,d)pyran | 4 | 25 | 1 | 10 | 25
Hydroxyamphetamine | | 5 | | 1.25 | 6
4‑Hydroxybutanoic acid (GHB) | | 2 | | 0.5 | 50
Hydroxyfentanyl | | 0.005 | | 0.00125 | 0.0075
Hydroxy‑3‑methylfentanyl | | 0.005 | | 0.00125 | 0.0075
Hydroxypethidine | | 1 | | 0.25 | 3
Isomethadone | | 2 | | 0.5 | 3
Ketobemidone | | 2 | | 0.5 | 3
Lysergamide | | 0.015 | | 0.005 | 0.015
Lysergic acid | | 0.015 | | 0.005 | 0.015
Lysergic acid diethylamide (LSD) | | 0.015 | | 0.005 | 0.015
Lysergide | | 0.015 | | 0.005 | 0.015
Mecloqualone | | 5 | | 1.25 | 15
Meprodine | | 1 | | 0.25 | 1.5
Mescaline (3,4,5-Trimethoxyphenethylamine) | | 0.2 | | 0.05 | 2
Metazocine | | 7 | | 1.75 | 125
Methadol | | 5 | | 1.25 | 15
Methaqualone | | 5 | | 1.25 | 7.5
Methcathinone | | 5 | | 1.25 | 6
Methorphan | | 2 | | 0.5 | 3
1‑(4‑Methoxyphenyl)piperazine | | 1 | | 0.25 | 3
5-Methoxy‑Ü-methyltryptamine | | 1 | | 0.2 | 2
4‑methylaminorex | 1 | 2.5 | 0.25 | 1.25 | 6
Methyldesorphine | | 2 | | 0.5 | 3
3,4‑Methylenedioxyamphetamine (MDA) | 0.75 | 1 | 0.1 | 0.5 | 2

3,4‑Methylenedioxymethyl
amphetamine (MDMA)

0.75

1

0.1

0.5

2

3,4‑Methylenedioxy‑N‑ethyl
amphetamine (MDEA)

0.75

1

0.1

0.5

2

3‑Methylfentanyl | | 0.005 | | 0.00125 | 0.0075
2‑Methyl‑3‑morpholino‑1,1-diphenylpropane carboxylic acid (Moramide intermediate) | | 2 | | 0.5 | 3
1‑Methyl‑4‑phenylpiperidine-4-carboxylic acid (Pethidine intermediate C) | | 1 | | 0.25 | 3
1‑Methyl‑4‑phenyl-4-propionoxypiperidine | | 1 | | 0.25 | 3
3‑Methylthiofentanyl | | 0.005 | | 0.00125 | 0.0075
Metopon | | 2 | | 0.5 | 3
Mitragynine | | | | |
Monoacetylmorphine | | 1.5 | | 0.6 | 30
Moramide | | 1.5 | | 0.6 | 30
Morphan | | 1.5 | | 0.6 | 30
Morpheridine | | 1.5 | | 0.6 | 30
Morphinone | | 1.5 | | 0.6 | 30
Muscimol | | 2 | | 0.5 | 125
Myrophine | | 20 | | 5 | 30
Nicocodine | | 4 | | 1 | 500
Nicodicodine | | 4 | | 1 | 500
Nicomorphine | | 4 | | 1 | 500
Noracylmethadol | | 2 | | 0.5 | 3
Noracymethadol | | 5 | | 1.25 | 15
Norlevorphanol | | 1 | | 0.25 | 1.5
Normorphine | | 20 | | 5 | 30
Norpipanone | | 10 | | 2.5 | 15
Opium (except where it is a drug of dependence) | | 4 | | 1 | 30
Parafluorofentanyl | | 0.005 | | 0.00125 | 0.0075
Parahexyl | | 0.2 | | 0.05 | 5
Paramethoxyamphetamine (4‑Methoxyamphetamine or PMA) | 0.75 | 1 | 0.1 | 0.5 | 2
Paramethoxymethamphetamine (PMMA) | 0.75 | 1 | 0.1 | 0.5 | 2
Phenacylmorphan | | 4 | | 1 | 250
Phenadoxone | | 10 | | 2.5 | 15
Phenampromide | | 10 | | 2.5 | 15
Phenazocine | | 1 | | 0.25 | 1.5
Phencyclidine | | 0.004 | | 0.001 | 0.0075
Phenethylamines (not otherwise listed in this Schedule) | 0.75 | 1 | 0.1 | 0.5 | 2
Phenomorphan | | 5 | | 1.25 | 7.5
1‑(1‑Phenylcyclohexyl)pyrrolidine | | 0.004 | | 0.001 | 0.0075
1‑Phenylethyl‑4‑acetoxypiperidine | | 0.004 | | 0.001 | 0.0075
1‑(2‑Phenylethyl)‑4‑phenyl‑4-acetyloxypiperidine (PEPAP) | | | | |
4‑Phenylpiperidine‑4‑carboxylic acid ethyl ester | | 1 | | 0.25 | 3
Piminodine | | 10 | | 2.5 | 15
Piritramide | | 1 | | 0.25 | 1.5
Prodine | | 1 | | 0.25 | 1.5
Proheptazine | | 1 | | 0.25 | 1.5
Properidine | | 28 | | 7 | 40
Propoxyphene | | 2 | | 0.5 | 250
Psilocin (3-(2‑Dimethylaminoethyl)‑4-hydroxyindole) | | 1 | | 0.25 | 100
Psilocybin | | 1 | | 0.25 | 100
Rolicyclidine (PHP or PCPY) | | 0.004 | | 0.001 | 0.0075
Salvinorin A | | 0.2 | | 0.05 | 5
Tenocyclodine (TCP) | | 0.004 | | 0.001 | 0.0075

Tetrahydrocannabinol (other than tetrahydrocannabinols—
	(a)	included in Part 2 of this Schedule;
	(b)	at a level not exceeding 50 mg/kg contained in hemp seed oil labelled "not for human internal use or consumption";
	(c)	at a level not exceeding 50 mg/kg contained in a product containing hemp seed oil designed for human external use only)

2

12.5

1

2.5

250

Thiambuten | | 5 | | 1.25 | 7.5
1‑(1‑(2‑Thienyl)cyclohexyl)piperidine | | 0.004 | | 0.001 | 0.0075
Thiofentanyl | | 0.005 | | 0.00125 | 0.0075
1‑(3‑Trifluoromethylphenyl)piperazine (TFMPP) | | 1 | | 0.2 | 2
Trimeperidine | | 10 | | 2.5 | 15
Tryptamines (not otherwise listed in this Schedule) | | 1 | | 0.2 | 2
Part 2—Drugs of dependence
Note—
A reference in the table below to schedule 2, 3 or 4 is a reference to the corresponding schedule of the Uniform Poisons Standard as incorporated into the Controlled Substances (Poisons) Regulations 1996.

| Large commercial (pure) | Large commercial (mixed) | Commercial (pure) | Commercial (mixed) | Trafficable (mixed)
| kg | kg | kg | kg | g
Acetyldihydrocodeine | | 10 | | 2.5 | 15
Acetylmethadol | | 5 | | 1.25 | 15
Alfentanil | | 2 | | 0.5 | 3
Alphacetylmethadol | | | | |
Alphaprodine | | | | |
Amphetamine | 0.75 | 1 | 0.1 | 0.5 | 2
Amylobarbitone (except when included in schedule 4) | | 4 | | 1 | 125
Anileridine | | 10 | | 2.5 | 15
Benzylmorphine (3‑benzylmorphine) | | 5 | | 1.25 | 7.5
Bezitramide | | 5 | | 1.25 | 7.5
Buprenorphine | | 0.04 | | 0.01 | 0.06
Butobarbitone | | 4 | | 1 | 125
Butorphanol | | 2 | | 0.5 | 3
Carfentanyl | | 0.005 | | 0.00125 | 0.0075
Cocaine | 0.75 | 1 | 0.1 | 0.2 | 2
Codeine (except when included in schedule 2, 3 or 4)) | | 2 | | 0.5 | 125
Codeine‑N‑oxide | | 10 | | 2.5 | 15
Cyclobarbitone | | 4 | | 1 | 125
Dexamphetamine | | | | |
Dextromoramide | | | | |
Dextropropoxyphene (except when included in schedule 4) | | | | |
Difenoxin (except when included in schedule 4) | | 2 | | 0.5 | 100
Dihydrocodeine (except when included in schedule 2, 3 or 4) | | 10 | | 2.5 | 250
Dihydromorphine | | 10 | | 2.5 | 250
Diphenoxylate (except when included in schedule 3 or 4) | | 2 | | 0.5 | 125
Dipipanone | | 10 | | 2.5 | 125
#Dronabinol (delta‑9-tetrahydrocannabinol) when prepared and packed for therapeutic use | | | | |
Drotebanol | | 1 | | 0.25 | 3
Ethylamphetamine | | | | |
Ethylmorphine (except when included in schedule 2 or 4) | | 2 | | 0.5 | 3
Fentanyl | | 0.005 | | 0.00125 | 0.0075
Flunitrazepam | | 1.5 | | 0.6 | 30
Hydrocodone | | 2 | | 0.5 | 3
Hydromorphinol | | 2 | | 0.5 | 3
Hydromorphone | | 2 | | 0.5 | 3
Ketamine | | 2 | | 0.5 | 6
Levamphetamine | | | | |
Levomethamphetamine | | | | |
Levomoramide | | | | |
Levorphanol | | 1 | | 0.25 | 1.5
Methadone | | 20 | | 4 | 400
Methylamphetamine (Methamphetamine) | 0.75 | 1 | 0.1 | 0.5 | 2
Methyldihydromorphine | | 2 | | 0.5 | 3
Methylphenidate | | 2 | | 0.5 | 3
Moramide | | | | |
Morphine | | 1 | | 0.2 | 20
Morphine methobromide | | 1.5 | | 0.6 | 30
Morphine‑N‑oxide | | 1.5 | | 0.6 | 30
Nabilone | | 0.4 | | 0.1 | 0.6
Norcodeine | | 4 | | 1 | 500
Normethadone | | 5 | | 1.25 | 7.5
Opium (except the alkaloids noscapine in schedule 2 and papaverine when included in schedule 2 or 4) | | 4 | | 1 | 30
Oxycodone | | 5 | | 1.25 | 7.5
Oxymorphone | | 2 | | 0.5 | 3
Pentazocine | | 5 | | 1.25 | 125
Pentobarbitone (except when included in schedule 4) | | 4 | | 1 | 125
Pethidine | | 1 | | 0.2 | 20
Phendimetrazine | | 10 | | 2.5 | 15
Phenmetrazine | | 5 | | 1.25 | 7.5
Phenoperidine | | 5 | | 1.25 | 7.5
Pholcodine (except when included in schedule 2 or 4) | | 5 | | 1.25 | 7.5
Piritramide | | | | |
Propiram | | 2 | | 0.5 | 3
Quinalbarbitone | | 4 | | 1 | 125
Racemoramide | | | | |
Remifentanil | | 0.2 | | 0.05 | 0.3
Secbutobarbitone | | 4 | | 1 | 125
Sufentanil | | 0.005 | | 0.00125 | 0.0075
Thebacon | | 2 | | 0.5 | 3
Thebaine | | 2 | | 0.5 | 3
Tilidine | | 1 | | 0.25 | 3
Schedule 2—Controlled Precursors

| Large commercial (pure) | Commercial (pure)
| kg / L | kg / L
Acetaldehyde | 2 kg | 0.5 kg
Acetic anhydride | 4 L | 1 L
N‑Acetylanthranilic acid | 20 kg | 5 kg
Allylbenzene | 1 L | 0.25 L
Allylpyrocatechol | 0.4 L | 0.1 L
Alpha‑phenylacetoacetonitrile | 2 kg | 0.5 kg
4‑Aminobutanoic acid | 6 kg | 1.5 kg
Ammonia | 6 kg | 1.5 kg
Ammonium formate | 2 kg | 0.5 kg
Anthranilic acid | 20 kg | 5 kg
Benzaldehyde | 2 L | 0.5 L
1,3‑Benzodioxole | 1 L | 0.25 L
Benzyl bromide | 2 L | 0.5 L
Benzyl chloride | 2 L | 0.5 L
Boron tribromide | 1 L | 0.25 L
Bromobenzene | 2 L | 0.5 L
5-Bromo‑1,3‑benzodioxole | 1 L | 0.25 L
Bromosafrole | 0.2 L | 0.05 L
1,4‑Butanediol | 6 L | 1.5 L
Calcium | 1 kg | 0.25 kg
1‑Chlorophenyl‑2‑aminopropane | 1 kg | 0.25 kg
Chromic acid | 0.4 L | 0.1 L
Chromium trioxide | 0.4 kg | 0.1 kg
Ephedrine | 1 kg | 0.25 kg
Ergometrine | 0.0002 kg | 0.00005 kg
Ergotamine | 0.02 kg | 0.005 kg
Ethanamine | 2 L | 0.5 L
Ethyl phenyl acetate | 2 kg | 0.5 kg
N‑Ethylephedrine | 1 kg | 0.25 kg
N‑Ethylpseudoephedrine | 1 kg | 0.25 kg
Eugenol | 0.4 L | 0.1 L
Formaldehyde | 6 kg | 1.5 kg
Formamide | 2 L | 0.5 L
Hydriodic acid | 4 L | 1 L
Hydrobromic acid | 1 L | 0.25 L
Hydrogen | 6 kg | 1.5 kg
Hydrogen chloride | 6 kg | 1.5 kg
Hydrogen sulfide | 6 kg | 1.5 kg
4‑Hydroxybutanal | 6 L | 1.5 L
4‑Hydroxybutanoic acid lactone | 6 L | 1.5 L
4‑Hydroxybutanoic acid nitrile | 6 L | 1.5 L
4‑Hydroxypentanoic acid | 6 L | 1.5 L
2‑Hydroxytetrahydrofuran | 6 L | 1.5 L
Hypophosphite salts | 1 kg | 0.25 kg
Hypophosphorous acid | 1 L | 0.25 L
Iodine | 1 kg | 0.25 kg
Isosafrole | 0.4 L | 0.1 L
Lithium | 1 kg | 0.25 kg
Lithium aluminium hydride | 0.2 kg | 0.05 kg
Lysergic acid | 0.0002 kg | 0.00005 kg
Magnesium | 1 kg | 0.25 kg
Mandellic acid | 2 kg | 0.5 kg
Mercuric chloride | 0.004 kg | 0.001 kg
Mercury | 0.004 kg | 0.001 kg
Methcathinone | 1 kg | 0.25kg
Methylamine | 2 L | 0.5 L
Methylammonium salts | 1 kg | 0.25 kg
3,4‑Methylenedioxyphenylacetic acid | 0.4 kg | 0.1 kg
3,4‑Methylenedioxyphenylpropan-2‑one (PMK) | 0.2 kg | 0.05 kg
N‑Methylformamide | 2 L | 0.5 L
N‑Methylephedrine | 1 kg | 0.25 kg
Methyl phenylacetate | 2 kg | 0.5 kg
N‑Methylpseudoephedrine | 1 kg | 0.25 kg
Methylstyrene | 2 L | 0.5 L
Nitroethane | 2 L | 0.5 L
Nitromethane | 2 L | 0.5 L
Norpseudoephedrine | 1 kg | 0.25 kg
Palladium | 0.02 kg | 0.005 kg
Phenylacetamide | 2 kg | 0.5 kg
Phenylacetic acid | 2 kg | 0.5 kg
Phenylacetonitrile | 2 L | 0.5 L
Phenylacetyl chloride | 2 L | 0.5 L
Phenylalanine | 2 kg | 0.5 kg
1‑Phenyl‑2‑bromopropane | 2 kg | 0.5 kg
1‑Phenyl‑2‑chloropropane | 2 kg | 0.5 kg
1‑Phenyl‑2‑iodopropane | 2 kg | 0.5 kg
1‑Phenyl‑2‑nitropropene | 1 kg | 0.25 kg
Phenylpropanolamine | 2 kg | 0.5 kg
1‑Phenyl‑2‑propanol | 1 L | 0.25 L
1‑Phenyl‑1‑Propanone | 1 L | 0.25 L
1‑Phenyl‑2‑propanone (BMK) | 1 L | 0.25 L
1‑Phenyl‑2‑propanone oxime | 1 kg | 0.25 kg
Phosphorus | 0.4 kg | 0.1 kg
Phosphorous acid | 1 L | 0.25 L
Piperidine | 0.2 kg | 0.05 kg
Piperonal | 0.4 kg | 0.1kg
Platinum | 0.02 kg | 0.005 kg
Potassium | 1 kg | 0.25 kg
Propionic anhydride | 0.2 L | 0.05 L
Pseudoephedrine | 1 kg | 0.25 kg
Pyridine | 4 L | 1 L
2-Pyrrolidone | 6 L | 1.5 L
Raney nickel | 0.2 kg | 0.05 kg
Safrole | 0.4 L | 0.1 L
Sassafras oil | 0.4 L | 0.1 L
Sodium | 1 kg | 0.25 kg
Sodium bis(2‑methoxyethoxy) aluminium hydride | 0.2 kg | 0.05 kg
Sodium borohydride | 0.2 kg | 0.05 kg
Sodium cyanoborohydride | 0.2 kg | 0.05 kg
Thionyl chloride | 1 kg | 0.25 kg
Thorium | 4 kg | 1 kg
Schedule 3—Controlled Plants
Part 1—Controlled plants other than cannabis plants

| Large commercial | Commercial | Trafficable
any plant of the genus Erythroxylum P. Browne) from which cocaine can be extracted either directly or by chemical transformation, including Erythroxylum coca Lam and Erythroxylum nova‑granatense | 800kg | 80kg | 800g
Papaver bracteatum Lindley | (a)	if each plant weighs less than 100g—10 000 plants; or | (a)	if each plant weighs less than 100g—1000 plants; or | (a)	if each plant weighs less than 10g—100 plants; or
| (b)	in any other case—1000kg | (b)	in any other case—100kg | (b)	in any other case—1kg
Papaver somniferum L | (a)	if each plant weighs less than 100g—10 000 plants; or | (a)	if each plant weighs less than 100g—1000 plants; or | (a)	if each plant weighs less than 10g—100 plants; or
| (b)	in any other case—1000kg | (b)	in any other case—100kg | (b)	in any other case—1kg
all fungi that contain PSILOCIN | 10kg | 2.5kg | 1000g
all fungi that contain PSILOCYBIN | 10kg | 2.5kg | 1000g
any plant containing MESCALINE including any plant of the genus Lophophora | | |
any plant containing DMT including any plant of the species Piptadenia Peregrina | | |
Salvia divinorum EPL. & Jativa (Diviners Sage) | | |
Mitragyna speciosa Korth (Kratom) | | |
Catha edulis Forsk (Khat) | 5kg | 2.5kg | 250g
any species of the genus Ephedra which contains ephedrine | 200kg | 50kg | 10kg
any species of the genus Brugmansia Pers | | |
any species of the genus Datura L | | |

Part 2—Cannabis plants

| Large commercial | Commercial | Trafficable
any plant of the genus Cannabis L | 100 plants | 20 plants | 10 plants
13—Insertion of Schedule 5
After Schedule 4 insert:
Schedule 5—Expiation Fees

1 | Offence arising out of the possession of cannabis— |
| •	where the amount is less than 25g | $150
| •	where the amount is 25g or more but less than 100g | $300
2 | Offence arising out of the possession of cannabis resin— |
| •	where the amount is less than 5g | $150
| •	where the amount is 5g or more but less than 20g | $300
3 | Offence arising out of the smoking or consumption of cannabis or cannabis resin (not being an offence committed in a public place or other prescribed place) | $150
4 | Offence arising out of the possession of equipment (1 or more pieces) for use in connection with the smoking or consumption of cannabis or cannabis resin (not being an offence involving the possession of such equipment for commercial purposes) | $150
5 | Offence referred to in item 4 accompanied by another simple cannabis offence relating to the possession, smoking or consumption of cannabis or cannabis resin | $30
6 | Offence involving cultivation of 1 cannabis plant | $300

Schedule 1—Revocation
1—Revocation of Controlled Substances (Expiation of Simple Cannabis Offences) Regulations 2002
The Controlled Substances (Expiation of Simple Cannabis Offences) Regulations 2002 are revoked.
2—Revocation of Controlled Substances (Exemptions) Regulations 2004
The Controlled Substances (Exemptions) Regulations 2004 are revoked.
Note—
As required by section 10AA(2) of the Subordinate Legislation Act 1978, the Minister has certified that, in the Minister's opinion, it is necessary or appropriate that these regulations come into operation as set out in these regulations.
Made by the Governor
after consultation by the Minister with the Controlled Substances Advisory Council and with the advice and consent of the Executive Council
on 22 November 2007
No 264 of 2007
AGO0235/02CS